Fig. 5: Tumor microenvironment analysis between high-BCIS and low-BCIS groups.

TIDE analysis in high-BCIS and low-BCIS groups, including (A) Stromal score, Immune score, ESTIMATE score and Tumor purity (B) MDSC, Exclusion, TIDE score and Dysfunction. C The role of BCIS in predicting immunotherapeutic benefit. TCR Shannon and TCR Richness between high-BCIS and low-BCIS groups.